Source: Health Products Regulatory Authority (ZA) Revision Year: 2012 Publisher: Pfizer Laboratories (Pty) Ltd, 85 Bute Lane, Sandton, 2196
ONICIT (solution for injection).
| Pharmaceutical Form |
|---|
|
Solution for injection. Clear, essentially colourless solution free from evidence of contamination. |
Each 1 ml of solution contains 50 micrograms palonosetron (as hydrochloride).
Each vial of 5 ml of solution contains 250 micrograms palonosetron (as hydrochloride). ONICIT solution is an isotonic solution for injection.
Inactive excipients: Mannitol, disodium edetate, sodium citrate, citric acid monohydrate, water for injection, sodium hydroxide solution and hydrochloric acid solution.
| Active Ingredient | Description | |
|---|---|---|
| Palonosetron |
Palonosetron is a selective high-affinity receptor antagonist of the 5HT3 receptor. |
| List of Excipients |
|---|
|
|
ONICIT is supplied in a Type I glass vial with grey chlorobutyl rubber stopper and blue aluminium cap. It is available in packs of 1 vial containing 5 ml of solution.
Pfizer Laboratories (Pty) Ltd, 85 Bute Lane, Sandton, 2196
A40/5.10/0322
| Drug | Countries | |
|---|---|---|
| ONICIT | Brazil, Mexico, New Zealand, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
